IL6 and central nervous system cancer: This work is significant because it characterizes the pivotal role of the IL6-p-STAT3-MIR155-3p pathway in hypoxia-induced autophagy in glioma cells, and this is the first demonstration of the therapeutic efficacy of IL6 receptor monoclonal antibody injection for the treatment of gliomas in vivo.